Mono- and Diglycerides of Fatty Acids

What this is

Regulators generally treat mono- and diglycerides as a conventional lipid-derived emulsifier rather than a high-concern additive. FDA affirms them as GRAS with use limited by current good manufacturing practice, JECFA assigned an ADI not limited, and Codex permits INS 471 Table 3 uses under GMP. EFSA's 2017 re-evaluation found no safety concern at reported uses, but later EFSA work and EU rules focused on tighter specifications for toxic elements, residual solvents, trans fatty acids, erucic acid, 3-MCPD, and glycidyl esters. Separately, recent French cohort studies reported associations between higher emulsifier or E471 exposure and cancer or cardiovascular outcomes. Those studies are observational and do not prove causation, but they justify keeping the concern tier above Low. California's 2025 school-food law may also indirectly affect some E471-containing ultra-processed school foods after rulemaking; it is not an E471-specific ban.

Safety Review

The key endpoints PRūF reviews in safety assessments. This is not a prediction of harm.

Regulatory toxicology is generally reassuring: E471 is expected to hydrolyze to ordinary lipid-digestion products, and JECFA/EFSA reviews did not identify a direct safety concern. The concern to spell out is uncertainty: EU specifications target toxic elements, trans fats, erucic acid, 3-MCPD, and glycidyl esters, and recent NutriNet-Sante observational studies reported associations with cancer and cardiovascular outcomes without proving causality.